The present invention provides a bioceramic based polymer nanoconjugates of bisphosphonate for treatment of osteoporosis. Nano-conjugates composition for regulated release of antiresorptive agent comprising of bioceramic in aqueous phase and also containing respective PLGA and mPEG in organic phase wherein: - The ratio of PLGA to PEG may range from 1:1 to 5:2. The ratio of bisphosphonate and hydroxy apatite range from 1:1 to 4:1 - The size of nanoconjugates varies from 50nm to 500nm. - The entrapment efficiency may be in the range of 50 ± 2.5% to 93 ± 3.0%